Skip to main content
Caplight Logo









Mecuris

Mecuris

Private
MunichHealthcare & Life Scienceshttps://mecuris.com

Last Round

Series A

Extension

Jan 13, 2020

Total Funding Raised

$8.13M

Company Overview

Mecuris operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Series A Extension round in January 2020.

Mecuris is a medical technology company that developed a digital platform for creating customized, 3D-printed orthotics and prosthetics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Mecuris Comparables

Compare Mecuris with similar companies based on industry and business-model similarity.

Mecuris comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vytruve
86%
Spentys
83%
Invent Medical Group
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Mecuris Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 13, 2020
Series AJan 16, 2019
SeedNov 21, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Mecuris Investors

Notable investors and investment history

Mecuris investors
InvestorRounds
Bayern KapitalSeries A, Series A Extension, Seed
Sana KlinikenSeries A

Mecuris Filings

Explore SEC and related filing metadata, where available.

Mecuris filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Mecuris's valuation, stock price, and market status.

Is Mecuris a public or private company?

Mecuris is a private company.

What is the current stock price of Mecuris?

Mecuris is a private company, so its shares have no public market price. Caplight tracks Mecuris's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Mecuris worth (valuation)?

Valuation information for Mecuris is not publicly available.

Can I buy Mecuris stock?

Mecuris shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Mecuris's last funding round?

Mecuris's most recent funding round was Series A Extension on January 13, 2020.

Who are the main investors in Mecuris?

Key investors in Mecuris include Bayern Kapital, Sana Kliniken.

Will Mecuris IPO soon?

No public IPO plans have been announced for Mecuris.

How can I track Mecuris secondary market activity?

Caplight tracks bids, offers, and trades in Mecuris's shares on secondary markets.

Firmographic Details

HeadquartersMunich
Employee Range5
Year Founded2016
Last FundingJan 13, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?